Marmar Charles R, Neylan Thomas C, Schoenfeld Frank B
Department of Psychiatry, University of California, Department of Veterans Affairs Medical Center, San Francisco, California, USA.
Psychiatr Q. 2002 Winter;73(4):259-70. doi: 10.1023/a:1020459916113.
Advances in psychopharmacology of PTSD are presented, focusing on antidepressants, adrenergic agents, antianxiety agents, and mood stabilizers. Treatment recommendations are related to recent advances in the understanding of the biology of PTSD. Pharmacotherapy of PTSD in children and adolescents is discussed, including recommended dose ranges. Recommendations are specified for pharmacotherapy of trauma survivors in the immediate aftermath of traumatic exposure, and for those with acute and chronic posttraumatic stress disorders.
介绍了创伤后应激障碍（PTSD）心理药理学的进展，重点关注抗抑郁药、肾上腺素能药物、抗焦虑药和心境稳定剂。治疗建议与PTSD生物学认识的最新进展相关。讨论了儿童和青少年PTSD的药物治疗，包括推荐剂量范围。明确了针对创伤暴露后即刻的创伤幸存者以及急性和慢性创伤后应激障碍患者的药物治疗建议。
